Department of Neurosurgery, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Department of Neurosurgery, Weifang People's Hospital, Weifang, Shandong, China.
Acta Neurochir (Wien). 2024 Aug 26;166(1):351. doi: 10.1007/s00701-024-06244-2.
Microvascular decompression (MVD) is a well-established and effective treatment for primary trigeminal neuralgia (TN). Endoscopy has been implemented to provide a comprehensive view of neurovascular conflict and minimizes the damages of brain retraction during MVD.
To preliminarily evaluate the surgical safety and efficacy of fully endoscopic microvascular decompression (EMVD) for primary TN with surgeon performing two-hand manipulation and assistant holding endoscope.
Retrospective clinical analysis of 189 patients with primary TN underwent EMVD between June 2019 and August 2022 was performed. By analyzing the intraoperative situation, the outcomes of postoperative symptoms and the main complications, we evaluated the reliability and effectivity of the operative technique in the treatment of primary TN.
We summarized the standard operating procedure of EMVD for primary TN with surgeon performing two-hand manipulation and assistant holding endoscope. In addition, acicular bipolar electrocoagulation technique was developed to handle venous compression. During the follow-up period, good pain relief was achieved in 178 patients (94.2%) and recurrence of pain was observed in 4 patients (2.1%). Postoperative temporary complications included trigeminal dysesthesias (7 patients, 4.8%), cerebrospinal fluid leak (2 patients, 1.1%), hearing difficulty (3 patient, 1.6%), facial paresis (2 patients, 1.1%) and vertigo (5 patients, 2.7%). There were no cases of intracranial hemorrhage, cerebellar swelling and death.
This EMVD technique is reliable and effective, and can be used as a routine surgical procedure for primary TN.
微血管减压术(MVD)是治疗原发性三叉神经痛(TN)的一种成熟且有效的方法。内镜的应用可以提供全面的神经血管冲突视图,并最大限度地减少 MVD 过程中脑牵拉的损伤。
初步评估术者双手操作、助手持镜的全内镜下微血管减压术(EMVD)治疗原发性 TN 的手术安全性和疗效。
回顾性分析 2019 年 6 月至 2022 年 8 月期间 189 例原发性 TN 患者行 EMVD 的临床资料。通过分析术中情况、术后症状缓解结果及主要并发症,评估该术式治疗原发性 TN 的可靠性和有效性。
总结了术者双手操作、助手持镜的全内镜下微血管减压术治疗原发性 TN 的标准操作流程。此外,还开发了针对静脉压迫的针尖双极电凝技术。在随访期间,178 例(94.2%)患者疼痛缓解良好,4 例(2.1%)患者出现疼痛复发。术后暂时性并发症包括三叉神经感觉异常(7 例,4.8%)、脑脊液漏(2 例,1.1%)、听力障碍(3 例,1.6%)、面瘫(2 例,1.1%)和眩晕(5 例,2.7%)。无颅内出血、小脑肿胀和死亡病例。
该 EMVD 技术安全有效,可作为原发性 TN 的常规手术方法。